Skip to Content

Kymera Therapeutics

KYMR

Buy $KYMR at eToro
Rank 3011
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address 300 TECHNOLOGY SQUARE, 2ND FLOOR, CAMBRIDGE, MA, US

Kymera Therapeutics - Key figures

Market cap 1.05 Billion
Revenue 63.75 Million
Profit -64,185,000
P/E Ratio No information
P/s Ratio 16.46
Buy $KYMR at eToro

Kymera Therapeutics - Description

Kymera Therapeutics, Inc., a biopharmaceutical company, is focused on discovering and developing new small molecule treatments that selectively break down disease-causing proteins by harnessing the body's own natural protein breakdown system.

The company is headquartered in Watertown, Massachusetts.